Mochida’s Epadel Hastily Added to Review List for PAFSC’s Committee on Non-Prescription Drugs

October 16, 2012
The switch OTC version of the hyperlipidemia treatment Epadel (ethyl icosapentate) from Mochida Pharmaceutical has been hastily added to the items for review by the Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Committee on Non-Prescription Drugs, which will be held...read more